20:53 Thu 08 Aug 2019
Collagen Sol PLC - Director/PDMR Shareholding
8 August 2019
("
Director / PDMR Dealing
The Company today announces that,
The Options will vest in three equal tranches on the first, second and third anniversaries of the date of grant. Such vesting will be conditional on his continued employment. In addition, the ability to exercise any vested Options will be dependent on achieving a closing middle market price per Share of
Notification and public disclosure of transactions by persons discharging managerial responsibilities and
persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | | |
2 | Reason for the notification |
|
a) | Position/status | Chief Executive Officer |
b) | Initial notification /Amendment | Initial Notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | | |
b) | LEI | 213800IFY1CVGRGETL95 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p each
ISIN Code: GB00B94T6Y14 |
b) | Nature of the transaction | Grant of options over ordinary shares of 1p each exercisable at 3.9p per share |
c) | Price(s) and volume(s) |
Price(s): Volume(s):
|
| Aggregated information
- Aggregated volume
- Price |
N/A
N/A |
e) | Date of the transaction | |
f) | Place of the transaction | Outside a trading venue |
For further information please contact:
|
| ||
| Via Walbrook | ||
|
| ||
|
| ||
Cenkos Securities Plc (Nominated Adviser and Broker) |
| ||
| Tel: 0207 397 8900 | ||
|
| ||
|
| ||
| Tel: 020 7933 8780 or collagen@walbrookpr.com | ||
| Mob: 07876 741 001 | ||
|
| ||
This information is provided by RNS, the news service of the
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE